MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
*Driving Forces: Life Sciences, Medical Devices & Health Information Technology
2025: Top 10 U.S. Biopharma Clusters 2025
Massachusetts
*Industry: Massachusetts
Centessa Pharmaceuticals plc (NASDAQ: CNTA)*
Finance & Acquisitions: Centessa
Parents
Centessa Pharmaceuticals plc (NASDAQ: CNTA)*
Children
2021: Additional blue-chip investors participated in the financing, including Boxer Capital, Cormorant Asset Management, T. Rowe Price Associates, Inc., Venrock Healthcare Capital Partners, Wellington Management Company, BVF Partners L.P., EcoR1 Capital, Franklin Templeton, Logos Capital, Samsara BioCapital, LifeSci Venture Partners and an undisclosed U.S.-based, healthcare-focused fund.
2021: Centessa Pharma, wasting no time, tees up $100M IPO
2021: Centessa Pharmaceuticals Begins U.S. IPO Effort
2021: Centessa-Pharmaceuticals-Launches-with-250-Million-Series-A-Financing-and-Unveils-a-New-Kind-of-Pharmaceutical-RD-Model
2021: Company Founded by Medicxi with Financing Led by General Atlantic, and Co-led by Vida Ventures and Janus Henderson Investors
2021: IPO Update: Centessa Pharmaceuticals Proposes U.S. IPO Terms_seekingalpha.com
2026: Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
Jumps
*Key People: Centessa
Organization & Developments: Centessa